Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yolanda Aebi"'
Autor:
Tanja Karpstein, Sheena Chaudhry, Solange Bresson-Hadni, Michael Hayoz, Ghalia Boubaker, Andrew Hemphill, Reto Rufener, Marc Kaethner, Isabelle Schindler, Yolanda Aebi, Antonio Sa Cunha, Carlo R. Largiadèr, Britta Lundström-Stadelmann
Publikováno v:
Pathogens, Vol 10, Iss 10, p 1335 (2021)
Drug-based treatment of alveolar echinococcosis (AE) with benzimidazoles is in most cases non-curative, thus has to be taken lifelong. Here, we report on a 56-year-old male AE patient who received standard benzimidazole treatment and biliary plastic
Externí odkaz:
https://doaj.org/article/4cd0299839024bd1a837f47aafb08760
Autor:
Ekaterina Gurevich, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Behrouz Mansouri Taleghani, Ulrike Bacher, Thomas Pabst
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1024
Gurevich, Ekaterina; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4) MDPI AG 10.3390/cancers14041024
Gurevich, Ekaterina; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4) MDPI AG 10.3390/cancers14041024
(1) Background: High-dose chemotherapy (HDCT) before autologous stem cell transplantation (ASCT) in acute myeloid leukemia (AML) patients predominantly combines busulfan with cyclophosphamide or melphalan. Treosulfan compares favorably regarding lowe
Autor:
Stefan Schürch, Markus Joerger, Yolanda Aebi, Barbara Büchel, Carlo R. Largiadèr, Johanna Sistonen
Publikováno v:
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Büchel, Barbara; Sistonen, Johanna; Joerger, Markus; Aebi, Yolanda; Schürch, Stefan; Largiadèr, Carlo Rodolfo (2013). Comparative evaluation of the My5-FU™ immunoassay and LC-MS/MS in monitoring the 5-fluorouracil plasma levels in cancer patients. Clinical chemistry and laboratory medicine, 51(8), pp. 1681-1688. De Gruyter 10.1515/cclm-2012-0641
Büchel, Barbara; Sistonen, Johanna; Joerger, Markus; Aebi, Yolanda; Schürch, Stefan; Largiadèr, Carlo Rodolfo (2013). Comparative evaluation of the My5-FU™ immunoassay and LC-MS/MS in monitoring the 5-fluorouracil plasma levels in cancer patients. Clinical chemistry and laboratory medicine, 51(8), pp. 1681-1688. De Gruyter 10.1515/cclm-2012-0641
Background: Chemotherapies of solid tumors commonly include 5-fluorouracil (5-FU). With standard doses of 5-FU, substantial inter-patient variability has been observed in exposure levels and treatment response. Recently, improved outcomes in colorect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b03454d3433a9d83d69b5ab772b8bb0f
http://doc.rero.ch/record/301463/files/cclm-2012-0641.pdf
http://doc.rero.ch/record/301463/files/cclm-2012-0641.pdf
Publikováno v:
Forensic Science International. 92:157-183
During the past decade, capillary electrophoresis (CE) emerged as a promising, effective and economic approach for separation of a large variety of substances, including those encountered in clinical toxicology. Reliable and automated CE instruments